News archive

Possible rapid and lasting antidepressant mechanisms of action of ketamine.

The Swedish Research Council has finalised funding for the Natural Sciences and Technology as well as the Humanities and Social Sciences. A total of 13 researchers at Karolinska Institutet will share more than SEK 37 m

Young people with lower school grades than their peers run a higher risk of mental ill-health and attempted suicide. In a new study published in the journal Acta Psychiatrica Scandinavica, researchers from Karolinska Institutet show that this risk persists into middle age.

Elisabeth Stener-Victorin has been promoted Professor in Reproductive Physiology at the Department of Physiology and Pharmacology, Karolinska Institutet from November 1, 2017.

On the 31 October the exhibition The Invisible Body opened at Sven-Harry’s Art Museum in Stockholm. A number of researchers at KI are represented by pictures from their own research.

In a recent publication in Molecular Human Reproduction, researchers at OnkPat could identify the specific proteome profiling of mouse ovarian follicles at three different developmental stages. To do that, the researchers isolated the follicles and cultured them in vitro. This is the first protein mapping of ovarian follicles ever published.

Researchers at Karolinska Institutet have identified an evolutionarily preserved scent molecule in mammalian blood that attracts predators and repels prey. In the study, published in Scientific Reports, they also report that humans exposed to the smell become stressed and react to it as if they were prey.

Mattias Carlström, associate professor at the Department of Physiology and Pharmacology at Karolinska Institutet, has been awarded the Prince Daniel research grant to promising young researchers of SEK 6 million from the Swedish Heart-Lung Foundation.

In the autumn of 2017, the STR received 5-year supporting funding of 4.5 million kr per year from the Swedish Research Council for research infrastructures of national importance.

To understand the cellular dialogue taking place on the cell surface – that is Gunnar Schulte’s ambition. More specifically, he is interested in how so-called Class Frizzled receptors work. The goal is to provide the foundation for new treatments of diseases that are linked to these receptors, such as various types of cancer and fibrosis.

Lars E. Gustafsson, Professor of Physiology at the Department of Physiology and Pharmacology, has passed away at the age of 67 after a period of illness.

When our immune system reacts to something in our environment, both our own bacterial flora as well as environmental microbiota play an important role. Harri Alenius is studying this interaction between the immune system and different microbiota – systems of microorganisms.

COMMENTARY: The prosecutor decided on Thursday to terminate the preliminary investigation into Paolo Macchiarini concerning the transplantation of artificial tracheae and other operations performed at Karolinska University Hospital, where he had been employed as a surgeon.

Atherosclerosis and valvular heart disease are common causes of heart conditions. Magnus Bäck is researching the molecular mechanisms which cause atherosclerosis and valvular heart disease, and how they can be turned to clinical benefit.

MedTechLabs is now open – the research centre formed by a close collaboration between Karolinska Institutet (KI), the Royal Institute of Technology (KTH) and Stockholm County Council (SLL). The objective of the centre’s first project is to develop technology to improve diagnosis and treatment of patients who have, for example, suffered a stroke.

Ingrid Kockum is researching into multiple sclerosis, MS, and is leading the major international collaboration MultipleMS. By combining many different types of data, the project will generate increased knowledge on various types of MS and how to better adapt the treatment to different patient groups.

Angel Cedazo Minguez is conducting research into Alzheimer’s disease. He wants to understand how the metabolism of cholesterol and insulin in the brain contributes to the onset of the disease. In the long-term, he hopes to develop new diagnostic methods and treatments for Alzheimer’s, before the disease gives symptoms.

Richard Rosenquist Brandell conducts research into how leukaemias arise, and how genetic markers can be used to assess prognosis and to select the most effective treatment. His research focusses primarily on chronic lymphatic leukaemia, CLL.